CR20130657A - Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo - Google Patents

Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo

Info

Publication number
CR20130657A
CR20130657A CR20130657A CR20130657A CR20130657A CR 20130657 A CR20130657 A CR 20130657A CR 20130657 A CR20130657 A CR 20130657A CR 20130657 A CR20130657 A CR 20130657A CR 20130657 A CR20130657 A CR 20130657A
Authority
CR
Costa Rica
Prior art keywords
test
lisyloxidase
homologist
methods
same
Prior art date
Application number
CR20130657A
Other languages
English (en)
Inventor
Victoria Smith
Joanne I Adamkewicz
Susan K Lyman
Jason Chien
Xiaoming Li
Lixin Shao
Jeffrey D Bornstein
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20130657(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of CR20130657A publication Critical patent/CR20130657A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)

Abstract

La presente descripción proporciona un ensayo para detectar y/o cuantificar polipéptidos circulantes de lisil oxidasa-homólogo 2 (LOXL2) en un individuo. El ensayo es útil en aplicaciones de diagnóstico y prognosis, las cuales también son proveídas.
CR20130657A 2011-06-01 2013-12-13 Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo CR20130657A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21

Publications (1)

Publication Number Publication Date
CR20130657A true CR20130657A (es) 2014-05-16

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20130657A CR20130657A (es) 2011-06-01 2013-12-13 Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo

Country Status (24)

Country Link
US (3) US20140206017A1 (es)
EP (1) EP2714744A1 (es)
JP (3) JP2014523521A (es)
KR (1) KR20140048156A (es)
CN (1) CN103946241A (es)
AP (1) AP2013007285A0 (es)
AR (1) AR086657A1 (es)
AU (2) AU2012261883A1 (es)
BR (1) BR112013030682A2 (es)
CA (1) CA2837534A1 (es)
CL (1) CL2013003445A1 (es)
CO (1) CO6940375A2 (es)
CR (1) CR20130657A (es)
EA (1) EA201391627A1 (es)
EC (1) ECSP13013092A (es)
IL (1) IL229631A0 (es)
MA (1) MA35212B1 (es)
MD (1) MD20130098A2 (es)
MX (1) MX2013013905A (es)
PE (1) PE20141450A1 (es)
TW (1) TW201319572A (es)
UY (1) UY34115A (es)
WO (1) WO2012167181A1 (es)
ZA (1) ZA201308812B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CN101835490A (zh) 2007-08-02 2010-09-15 阿雷斯托生物科学股份有限公司 Lox和loxl2抑制剂及其应用
WO2010080769A2 (en) 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
JP2013502226A (ja) 2009-08-21 2013-01-24 ギリアド バイオロジクス，インク． リシル酸化酵素及びｌｏｘｌ２由来の触媒ドメイン
JP6134142B2 (ja) 2010-02-04 2017-05-24 ギリアド バイオロジクス, インク.Gilead Biologics, Inc. リシルオキシダーゼ様２（ｌｏｘｌ２）に結合する抗体及びその使用方法
CN104755501A (zh) * 2012-10-30 2015-07-01 吉联亚科学公司 与赖氨酰氧化酶样蛋白2(loxl2)相关的治疗和诊断方法
US20150342943A1 (en) 2014-06-03 2015-12-03 Gilead Sciences, Inc. Methods of treating liver disease
CA2951535A1 (en) * 2014-06-11 2015-12-17 Gilead Sciences, Inc. Methods for treating cardiovascular diseases
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
WO2017152062A1 (en) 2016-03-04 2017-09-08 Gilead Sciences, Inc. Compositions and combinations of autotaxin inhibitors
US20170306050A1 (en) 2016-04-08 2017-10-26 Gilead Sciences, Inc. Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
WO2023091479A1 (en) * 2021-11-17 2023-05-25 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CN101835490A (zh) * 2007-08-02 2010-09-15 阿雷斯托生物科学股份有限公司 Lox和loxl2抑制剂及其应用
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
EP2470218A4 (en) * 2009-08-21 2013-04-03 Gilead Biologics Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROGEN DISORDERS
JP6134142B2 (ja) * 2010-02-04 2017-05-24 ギリアド バイオロジクス, インク.Gilead Biologics, Inc. リシルオキシダーゼ様２（ｌｏｘｌ２）に結合する抗体及びその使用方法
KR101889363B1 (ko) * 2011-05-10 2018-08-17 보르그워너 인코퍼레이티드 가변 터빈 지오메트리를 갖는 터보차저

Also Published As

Publication number Publication date
ZA201308812B (en) 2014-08-27
BR112013030682A2 (pt) 2016-12-06
UY34115A (es) 2013-01-03
US20170269085A1 (en) 2017-09-21
CA2837534A1 (en) 2012-12-06
MD20130098A2 (ro) 2014-06-30
CN103946241A (zh) 2014-07-23
PE20141450A1 (es) 2014-11-06
CL2013003445A1 (es) 2014-07-25
TW201319572A (zh) 2013-05-16
KR20140048156A (ko) 2014-04-23
MX2013013905A (es) 2014-05-14
ECSP13013092A (es) 2014-08-29
JP2016164578A (ja) 2016-09-08
AR086657A1 (es) 2014-01-15
US20140206017A1 (en) 2014-07-24
IL229631A0 (en) 2014-01-30
CO6940375A2 (es) 2014-05-09
AU2016244254B2 (en) 2018-10-18
US20120309020A1 (en) 2012-12-06
MA35212B1 (fr) 2014-06-02
WO2012167181A1 (en) 2012-12-06
AU2012261883A1 (en) 2013-05-02
NZ618682A (en) 2016-04-29
JP2014523521A (ja) 2014-09-11
EP2714744A1 (en) 2014-04-09
EA201391627A1 (ru) 2014-08-29
AU2016244254A1 (en) 2016-11-03
JP2018049033A (ja) 2018-03-29
AP2013007285A0 (en) 2013-11-30

Similar Documents

Publication Publication Date Title
ECSP13013092A (es) Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo
UY34306A (es) Pirimidinas condensadas sustituidas y su uso
UY34764A (es) Derivados de 2,2-difluoropropionamida de metilo de bardoxolona, formas polimórficas y sus métodos de uso
AR077237A1 (es) Polimeros colorantes
BR112015001592A8 (pt) análise de imagem e medidas de amostras biológicas
CO2019012771A2 (es) Ensayos de diagnóstico para detectar, cuantificar y/o rastrear microbios y otros analitos
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
ECSP13012461A (es) Ensayos biomarcadores para detectar o medir inhibición de actividad quinasa tor
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
AR082388A1 (es) Metodo para identificar un compuesto que tiene un efecto antiarritmico asi como los usos relacionados con el mismo
GT201400099A (es) Proteínas que pueden unirse a la il-1
BR112016008970A2 (pt) Método de ativação ex vivo e para avaliar ativação plasmática em um indivíduo, ensaio ex vivo para determinar atividade de calicreína plasmática em uma amostra
EA201590630A1 (ru) Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2)
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
CO2017005773A2 (es) Composiciones, dispositivos, y métodos de pruebas de sensibilidad del ibs
UY34160A (es) Ligandos del receptor trpm8 y su uso en diversos tratamientos
BR112017006315A2 (pt) agente terapêutico, uso de um agente terapêutico, métodos in vitro para determinar se um sujeito com melanoma tem um risco maior de desenvolver metástase, de determinação de um regime de tratamento para um sujeito que sofre de melanoma, de tratamento de um sujeito que sofre de melanoma, ensaio in vitro para predizer o risco aumentado de metástase e kits
UY34590A (es) Fenilimidazopirazoles sustituidos y su uso
BR112014032916A2 (pt) anticorpos anti-fármacos e usos destes para o monitoramento de fármaco
BR112016002709A2 (pt) queratinas como biomarcadores para câncer cervical e sobrevivência
EA201690434A1 (ru) Маркирующие соединения и их применение в анализах
CY1121482T1 (el) Ευαισθητη πολυπλεκτικη ανοσοδοκιμασια για τους διαλυτους υποδοχεις των αυξητικων παραγοντων των ινοβλαστων
BR112015001587B8 (pt) Método de ensaio de pcr para determinação da zigosidade de um gene rf4 em uma planta de milho